173 related articles for article (PubMed ID: 36986671)
1. System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy.
Zhu L; Ma M; Zhang L; Wang S; Guo Y; Ling X; Lin H; Lai N; Lin S; Du L; Dong Q
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986671
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
Front Oncol; 2021; 11():799223. PubMed ID: 35096599
[TBL] [Abstract][Full Text] [Related]
4. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
5. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
6. An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.
Xing X; Jia S; Leng Y; Wang Q; Li Z; Dong B; Guo T; Cheng X; Du H; Hu Y; Feng Q; Lian S; Luan F; Ma X; Li Z; Ni M; Li Z; Ji J
Oncoimmunology; 2020 Aug; 9(1):1792038. PubMed ID: 32939321
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism-related gene prognostic index (LMRGPI) reveals distinct prognosis and treatment patterns for patients with early-stage pulmonary adenocarcinoma.
Jiang A; Chen X; Zheng H; Liu N; Ding Q; Li Y; Fan C; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Int J Med Sci; 2022; 19(4):711-728. PubMed ID: 35582412
[No Abstract] [Full Text] [Related]
8. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer.
Liu L; Pang H; He Q; Pan B; Sun X; Shan J; Wu L; Wu K; Yao X; Guo Y
Cancer Cell Int; 2021 Jul; 21(1):335. PubMed ID: 34215253
[TBL] [Abstract][Full Text] [Related]
10. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
11. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
12. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
[TBL] [Abstract][Full Text] [Related]
13. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
14. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
Zhang Z; Fang T; Lv Y
Front Genet; 2022; 13():934830. PubMed ID: 36171887
[No Abstract] [Full Text] [Related]
15. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
16. AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer.
Wu F; Zhang L; Wang L; Zhang D
Int J Gen Med; 2022; 15():1865-1878. PubMed ID: 35264871
[TBL] [Abstract][Full Text] [Related]
17. A novel pyroptosis gene expression-based risk score for survival in gastric cancer.
Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F
Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic model based on epithelial-mesenchymal transition-related genes predicts patient survival in gastric cancer.
Song W; Bai Y; Zhu J; Zeng F; Yang C; Hu B; Sun M; Li C; Peng S; Chen M; Sun X
World J Surg Oncol; 2021 Jul; 19(1):216. PubMed ID: 34281542
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of critical genes with prognostic value in gastric cancer.
Dong N; Ma X; Shen J; Zheng Y; Li G; Zheng S; Huang X
Front Cell Dev Biol; 2022; 10():1072062. PubMed ID: 36589754
[No Abstract] [Full Text] [Related]
20. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
